Bausch Health Companies (BHC) Total Current Liabilities (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Total Current Liabilities came in at $4.5 billion in Q2 2026, down 8.66% year-over-year from $5.0 billion in Q2 2025, and little changed quarter-over-quarter from $4.5 billion in Q1 2026.
Analysis
Bausch Health Companies (BHC) Total Current Liabilities (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Total Current Liabilities across 18 years of filings, most recently posting $4.5 billion for Q2 2026.
- In Q2 2026, Total Current Liabilities fell 8.66% year-over-year to $4.5 billion; the TTM figure through Jun 2026 stood at $4.5 billion (down 8.66% YoY), while the FY2025 annual figure was $4.2 billion, down 38.09% from the prior year.
- Total Current Liabilities came in at $4.5 billion for Q2 2026 at Bausch Health Companies, roughly flat from $4.5 billion in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $6.8 billion in Q4 2024 to a low of $3.8 billion in Q3 2022.
- Average Total Current Liabilities over 5 years is $4.5 billion, with a median of $4.4 billion recorded in 2024.
- Year-over-year, Total Current Liabilities soared 56.95% in 2024 and plunged 38.09% in 2025.
- Over 5 years, Total Current Liabilities stood at $3.9 billion in 2022, then increased by 9.16% to $4.3 billion in 2023, then soared by 56.95% to $6.8 billion in 2024, then sank by 38.09% to $4.2 billion in 2025, then rose by 8.71% to $4.5 billion in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $4.5 billion in Q2 2026, $4.5 billion in Q1 2026, and $4.2 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | 15.65 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 6.35 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 1.66 Bn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 883.19 Mn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 4.54 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | 331.18 Mn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 283.66 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 263.21 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | 12.39 Mn |
| 10 | RedHill Biopharma | 171.02 Mn | 171.02 Mn | - | 19.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.54 Bn |
| Mar 31, 2026 | 4.53 Bn |
| Dec 31, 2025 | 4.18 Bn |
| Sep 30, 2025 | 4.79 Bn |
| Jun 30, 2025 | 4.98 Bn |
| Mar 31, 2025 | 4.26 Bn |
| Dec 31, 2024 | 6.75 Bn |
| Sep 30, 2024 | 4.51 Bn |
| Jun 30, 2024 | 4.37 Bn |
| Mar 31, 2024 | 4.41 Bn |
| Dec 31, 2023 | 4.30 Bn |
| Sep 30, 2023 | 4.22 Bn |
| Jun 30, 2023 | 3.97 Bn |
| Mar 31, 2023 | 3.92 Bn |
| Dec 31, 2022 | 3.94 Bn |
| Sep 30, 2022 | 3.83 Bn |
| Jun 30, 2022 | 5.00 Bn |
| Mar 31, 2022 | 4.77 Bn |
| Dec 31, 2021 | 5.20 Bn |
| Sep 30, 2021 | 5.44 Bn |